AU2002214519B2 - Inhalation of nitric oxide - Google Patents

Inhalation of nitric oxide Download PDF

Info

Publication number
AU2002214519B2
AU2002214519B2 AU2002214519A AU2002214519A AU2002214519B2 AU 2002214519 B2 AU2002214519 B2 AU 2002214519B2 AU 2002214519 A AU2002214519 A AU 2002214519A AU 2002214519 A AU2002214519 A AU 2002214519A AU 2002214519 B2 AU2002214519 B2 AU 2002214519B2
Authority
AU
Australia
Prior art keywords
nitric oxide
pulmonary
use according
acute
cyclooxygenase inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002214519A
Other languages
English (en)
Other versions
AU2002214519A1 (en
Inventor
Luni Chen
Goran Hedenstierna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INO Therapeutics LLC
Original Assignee
INO Therapeutics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INO Therapeutics LLC filed Critical INO Therapeutics LLC
Publication of AU2002214519A1 publication Critical patent/AU2002214519A1/en
Application granted granted Critical
Publication of AU2002214519B2 publication Critical patent/AU2002214519B2/en
Assigned to INO THERAPEUTICS, LLC reassignment INO THERAPEUTICS, LLC Request for Assignment Assignors: AGA AB
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002214519A 2000-11-17 2001-11-15 Inhalation of nitric oxide Ceased AU2002214519B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0004229-1 2000-11-17
SE0004229A SE0004229D0 (sv) 2000-11-17 2000-11-17 Inhalation of nitric oxide
PCT/SE2001/002542 WO2002040052A1 (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide

Publications (2)

Publication Number Publication Date
AU2002214519A1 AU2002214519A1 (en) 2002-08-01
AU2002214519B2 true AU2002214519B2 (en) 2004-08-12

Family

ID=20281873

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002214519A Ceased AU2002214519B2 (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
AU1451902A Pending AU1451902A (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU1451902A Pending AU1451902A (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide

Country Status (19)

Country Link
US (1) US20040028753A1 (de)
EP (1) EP1339428B1 (de)
JP (1) JP2004513928A (de)
CN (1) CN100443119C (de)
AR (1) AR031348A1 (de)
AT (1) ATE354375T1 (de)
AU (2) AU2002214519B2 (de)
CA (1) CA2429224A1 (de)
CZ (1) CZ20031617A3 (de)
DE (1) DE60126814T2 (de)
EE (1) EE200300226A (de)
ES (1) ES2282310T3 (de)
IL (1) IL155968A0 (de)
NZ (1) NZ526295A (de)
PL (1) PL362023A1 (de)
SE (1) SE0004229D0 (de)
SK (1) SK7312003A3 (de)
WO (1) WO2002040052A1 (de)
ZA (1) ZA200303845B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756047B2 (en) * 2000-05-12 2004-06-29 The University Of Toledo Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
US6750238B1 (en) 2000-05-12 2004-06-15 The University Of Toledo Aralkyl ester soft drugs
US7049326B2 (en) 2000-05-12 2006-05-23 The University Of Toledo Method and compositions for temporarily incapacitating subjects
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor
EP1400243A1 (de) * 2002-09-19 2004-03-24 Tanabe Seiyaku Co., Ltd. Aktivator von Kalzium-abhängiger Kaliumkanälen
US8518457B2 (en) * 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
DK176782B1 (da) * 2006-08-04 2009-08-17 Innovision As Fremgangsmåde til at kompensere for effekten af recirkulation af blodoplöselig gas på bestemmelse af pulmonal blodgennemströmning i gentagne tests med genånding af inert gas
US9573110B2 (en) 2011-10-03 2017-02-21 NitricGen, Inc. Apparatus and method for generating nitric oxide in controlled and accurate amounts
US20150174158A1 (en) * 2012-03-07 2015-06-25 Advanced Inhalation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
MX370384B (es) 2013-03-15 2019-12-11 Massachusetts Gen Hospital Sintesis de gas de oxido nitrico para inhalacion.
JP6689188B2 (ja) 2013-03-15 2020-04-28 ザ ジェネラル ホスピタル コーポレイション 一酸化窒素の吸気合成
AU2015336055B2 (en) 2014-10-20 2020-07-16 The General Hospital Corporation Systems and methods for the synthesis of nitric oxide
KR20190005839A (ko) 2016-03-25 2019-01-16 더 제너럴 하스피탈 코포레이션 산화질소의 전기 플라즈마 합성을 위한 전달 시스템 및 방법
WO2018157172A1 (en) 2017-02-27 2018-08-30 Third Pole, Inc. Systems and methods for generating nitric oxide
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
AU2018224329B2 (en) 2017-02-27 2019-11-28 Third Pole, Inc. Systems and methods for ambulatory generation of nitric oxide
CA3058472C (en) 2017-03-31 2020-05-26 The General Hospital Corporation Systems and methods for a cooled nitric oxide generator
EP3969416A4 (de) 2019-05-15 2023-11-01 Third Pole, Inc. Systeme und vorrichtungen zur erzeugung von stickoxid
JP2022533628A (ja) 2019-05-15 2022-07-25 サード ポール，インコーポレイテッド 一酸化窒素生成用電極
WO2021142472A1 (en) 2020-01-11 2021-07-15 Third Pole, Inc. Systems and methods for nitric oxide generation with humidity control
US20210395905A1 (en) 2020-06-18 2021-12-23 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
CA3218643A1 (en) * 2021-05-11 2022-11-17 Anil Gulati Pharmaceutical composition and method for treatment of acute respiratory distress syndrome (ards) in corona virus disease (covid-19)
WO2023049873A1 (en) 2021-09-23 2023-03-30 Third Pole, Inc. Systems and methods for delivering nitric oxide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537906A (en) * 1982-12-06 1985-08-27 Merck Frosst Canada, Inc. Substituted phenylalkenoic acids and esters
US4536515A (en) * 1982-12-06 1985-08-20 Merck Frosst Canada, Inc. Substituted phenylalkenoic acids and esters
WO1992010228A1 (en) * 1990-12-05 1992-06-25 The General Hospital Corporation Devices for treating pulmonary vasoconstriction and asthma
EP1246621A4 (de) * 1999-12-23 2004-11-24 Nitromed Inc Nitrosierte und nitrosylierte cyclooxygenase-2-inhibitoren, zusammensetzungen und methoden für deren verwendung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LIPPTON et al. Prostaglandius, 28(2) 1984, 253-270. *

Also Published As

Publication number Publication date
AU1451902A (en) 2002-05-27
SK7312003A3 (en) 2004-02-03
CA2429224A1 (en) 2002-05-23
NZ526295A (en) 2004-10-29
PL362023A1 (en) 2004-10-18
EP1339428B1 (de) 2007-02-21
JP2004513928A (ja) 2004-05-13
CN100443119C (zh) 2008-12-17
AR031348A1 (es) 2003-09-17
DE60126814T2 (de) 2007-10-25
IL155968A0 (en) 2003-12-23
EE200300226A (et) 2003-08-15
CN1481256A (zh) 2004-03-10
ZA200303845B (en) 2004-09-09
ATE354375T1 (de) 2007-03-15
DE60126814D1 (de) 2007-04-05
EP1339428A1 (de) 2003-09-03
CZ20031617A3 (cs) 2004-02-18
SE0004229D0 (sv) 2000-11-17
ES2282310T3 (es) 2007-10-16
US20040028753A1 (en) 2004-02-12
WO2002040052A1 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
AU2002214519B2 (en) Inhalation of nitric oxide
AU2002214519A1 (en) Inhalation of nitric oxide
AU688027B2 (en) Methods for treating pulmonary vasoconstriction and asthma
JP3718491B2 (ja) 吸入用装置
TWI474824B (zh) 血管活性氧載劑所引發之血管收縮之減輕
AU772858B2 (en) Method of treating cardio pulmonary diseases with no group compounds
US20080089956A1 (en) Nitric oxide in treatment of inflammation
US5418219A (en) Pharmaceutical composition for treatment of adult respiratory distress syndrome containing human ANP
US20050255178A1 (en) Enhancing the effectiveness of an inhaled therapeutic gas
RU2417083C2 (ru) Применение активаторов растворимой гуанилатциклазы для лечения острых и хронических легочных заболеваний
Hayward et al. Inhaled nitric oxide in cardiology practice
JPWO2003055481A1 (ja) 臓器線維化抑制剤
Ewert et al. Inhalative iloprost–pharmacology and clinical application
JPWO2005089743A1 (ja) 腎性貧血治療剤
Kirvela et al. Comparison of propofol/alfentanil anaesthesia with isoflurane/N2O/fentanyl anaesthesia for renal transplantation
EA007736B1 (ru) Комбинация ингибитора pde и антагониста лейкотриенового рецептора
Hogman et al. Increased airway osmolarity inhibits the action of nitric oxide in the rabbit
US20230000903A1 (en) Methods and systems for nitric oxide therapy for the treatment or prevention of respiratory infections
Helander et al. An Update on Nonopioids Intravenous or Oral Analgesics for Perioperative Pain Management
Berg et al. Novel approaches to drug delivery in critical care
Pinet et al. Association of oral almitrine and medroxyprogesterone acetate: effect on arterial blood gases in chronic obstructive pulmonary disease
Fineman et al. Pulmonary vascular regulation in newborns, infants and children after surgery for congenital heart disease
Wilson Management of the Transplant Patient in the Intensive Care Unit
Antoniou et al. Perioperative management of pulmonary hypertension
Scholte et al. Unresolving ARDS due to varicella: successful treatment with CVVH and corticosteroids

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: INO THERAPEUTICS, LLC

Free format text: FORMER OWNER WAS: AGA AB

MK14 Patent ceased section 143(a) (annual fees not paid) or expired